Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Godley, Lucy
Professor
Bio
The Godley laboratory studies the molecular pathways that drive hematopoietic malignancies, with a focus on understanding how germline predisposition alleles contribute to individual and family risk a... [more]
Gordon, Leo I.
Professor
Bio
Novel signaling pathways in lymphoma, using cell lines and animal model systems. More specifically, our research focuses on the biology of reactive oxygen species signaling pathways in lymphoma. Activ... [more]
Gradishar, William J.
Professor
Bio
My research focuses on the development of novel therapeutics for the treatment of breast cancer.
Guitart, Joan
Professor
Bio
Cutaneous T-cell lymphoma, Dermatopathology, Skin cancer prevention and detection.